These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35451408)

  • 1. Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients.
    Zhang X; Hu M; Li S; Sha S; Mao R; Liu Y; Li Q; Lu Q; Chen W; Zhang Y; Wang R; Xu H; Wang J; Qiao Y; Chen Z; Wu H; Pan Y; Wang Q; Zhang S; Yang F; Li J; Liu G; Xue X; Ji Y
    Medicine (Baltimore); 2022 Mar; 101(10):e29031. PubMed ID: 35451408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.
    Ji Y; Li S; Zhang X; Liu Y; Lu Q; Li Q; Chen W; Sheng J; Jiang K; Liang H; Sha S; Li M; Chen Z; Zheng P; Wang M; Feng Y; Wang L; Wu H; Liu H; Huang Y; Yin Z; Xue X
    Trials; 2020 Oct; 21(1):844. PubMed ID: 33046128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-κB pathway in treating rheumatoid arthritis.
    Wei X; Zhou R; Chen Y; Ma G; Yang Y; Lu C; Xu W; Hu W
    Bioorg Chem; 2022 Feb; 119():105519. PubMed ID: 34864624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
    Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
    Trials; 2015 Apr; 16():146. PubMed ID: 25873045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huang Bai Jian Pi decoction alleviates diarrhea and represses inflammatory injury via PI3K/Akt/NF-κB pathway: In vivo and in vitro studies.
    Yan Z; Zhang K; Zhang K; Wang G; Wang L; Zhang J; Qiu Z; Guo Z; Kang Y; Song X; Li J
    J Ethnopharmacol; 2022 Jun; 292():115212. PubMed ID: 35331876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
    Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
    Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Shengjiang Xiexin decoction in prophylaxis of chemotherapy-related diarrhea in small cell lung cancer patients: study protocol for a multicenter randomized controlled trial.
    Deng C; Lou Y; Gao Y; Deng B; Su F; Jia L
    Trials; 2020 May; 21(1):370. PubMed ID: 32357899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial.
    You JS; Guo L; Huang M; Shi XL; Lin MD; Guo Z; Cao YL; Sun YZ; Xu Q; Qu WL; Liu HL; Chen JP
    Trials; 2019 Dec; 20(1):719. PubMed ID: 31831051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and mechanism of Simiaoyongan decoction in the treatment of carotid atherosclerotic plaque: a randomized, double-blind, placebo-controlled clinical trial protocol.
    Fan Q; Tan Z; Su W; Li Q; Jin D; Du Y; Zhang L; Wu S
    BMC Complement Med Ther; 2024 Jul; 24(1):277. PubMed ID: 39039498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yanghe decoction attenuated pain hypersensitivity induced by michigan cancer foundation-7 injection in rats with bone metastases from breast cancer by inhibiting transient receptor potential ankyrin 1.
    Hui G; Yang LI; Lei F; Yujie X; Lizhong H; Dan M; Hui Z
    J Tradit Chin Med; 2022 Dec; 42(6):948-955. PubMed ID: 36378053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.
    Wu W; Deng H; Rao N; You N; Yang Y; Cao M; Liu J
    Trials; 2017 Oct; 18(1):497. PubMed ID: 29070044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
    Yu XQ; Yang SG; Xie Y; Li JS
    J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trial.
    Yap NY; Loo WS; Zheng HF; Tan QM; Tan TK; Quek LYP; Tan CJ; Toh YL; Ng CC; Ang SK; Tan VKM; Ho HK; Chew L; Loh KW; Tan TJY; Chan A
    Trials; 2020 Nov; 21(1):909. PubMed ID: 33187543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Saura C; Hlauschek D; Oliveira M; Zardavas D; Jallitsch-Halper A; de la Peña L; Nuciforo P; Ballestrero A; Dubsky P; Lombard JM; Vuylsteke P; Castaneda CA; Colleoni M; Santos Borges G; Ciruelos E; Fornier M; Boer K; Bardia A; Wilson TR; Stout TJ; Hsu JY; Shi Y; Piccart M; Gnant M; Baselga J; de Azambuja E
    Lancet Oncol; 2019 Sep; 20(9):1226-1238. PubMed ID: 31402321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of self-made Gengnian decoction on phosphatidylinositol 3-kinases/protein kinase B/mammalian target of rapamycin signaling pathway in perimenopausal rats.
    Zhang F; Cao J; Zhang X; Wang J; Yi X
    J Tradit Chin Med; 2019 Dec; 39(6):861-866. PubMed ID: 32186157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yanghe Huayan decoction inhibits the capability of trans-endothelium and angiogenesis of HER2+ breast cancer via pAkt signaling.
    Liu XF; Li JW; Chen HZ; Sun ZY; Shi GX; Zhu JM; Song AL; Wang Y; Li XQ
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30429238
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial.
    Wang Y; Xiao X
    Med Sci Monit; 2018 May; 24():2912-2918. PubMed ID: 29735967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Shenhuang paste on Shenque point improves chemotherapy induced gastrointestinal toxicity in breast cancer: A protocol for randomized controlled trial.
    Wang R; Shi Y; Xie X; Ge Q; Xu J; Sun Q; Xu X
    Medicine (Baltimore); 2021 Apr; 100(15):e25097. PubMed ID: 33847614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Jiang Y; Liu LS; Shen LP; Liu JX; Jiang GN; Gu AQ; Li HC; Li Q; Li HG; Huang PX
    Clin Lung Cancer; 2019 Sep; 20(5):e541-e547. PubMed ID: 31230892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.